CBG (cannabigerol) is definitely among the most essential cannabinoids in the cannabis plant. It is often identified as “the mother of all cannabinoids,” and also it holds potential as a answer to conditions including diabetes, ALS, as well as Huntington’s disease, despite the fact that human studies are seriously lacking. In addition to its likely professional medical applications, much like CBD, CBG is not really considered intoxicating and will not get you high.
The majority of the more common and well-known effects of THC and CBD are resulting from their relationship with the endocannabinoid system. CBG, even so, typically works through other mechanisms, which explains why it has such unique effects. It is currently being researched as a solution for a long list of ailments, including dementia, PTSD, ADHD, Huntington’s disease, ALS, Parkinson’s disease, multiple sclerosis, type 2 diabetes, colitis, and of course, pain.
Although it’s important to note that in regards to CBG the word “potential” is definitely of essence. Almost all of the evidence specialists are finding concerning the efficacy of CBG is based on animal models, consequently it’s too early to say whether they are relevant for people. And unlike THC and CBD, there’s practically no clinical specifics of the safety or dosing of CBG-dominant products and solutions.